RAC 1.11% $1.83 race oncology ltd

Theoretical Revenue Potential of RACE Oncology 5-path Strategy, page-58

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    I also have a better understanding now of the distribution of Phase II and Phase III trials amongst the different types of cancer ( see https://hotcopper.com.au/posts/41596009/single ).

    This means that I can update the summary table.

    See chart integrated into the table below - to highlight just how much Phase II and III data there is.

    That's an incredible asset for a microcap biotech (MCAP $15M as at 22 November 2019), particularly given the theoretical revenue potential.

    Screen Shot 2019-11-23 at 8.49.45 pm.png
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.